Up and running again

A Boston Scientific therapy helped Esther overcome cancer pain.

Read her story

Featured stories
May 2, 2024
Bridging gaps in care for the Asian-American community

See how Boston Scientific employees are helping more patients to get the treatments they need.

Apr 26, 2024
What is deep brain stimulation and how does it help Parkinson's symptoms?

Learn how DBS technology can provide patients with instant improvement.

Apr 26, 2024
Making sustainable progress for people and the planet: Our 2023 Performance Report

Patient health is interconnected with the health of communities and of our world. Learn how we advanced science for life this past year.

Read more stories

Press releases
May 8, 2024
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors

Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immediately. Dr. Pegus has more than 25 years of clinical and...

May 1, 2024
Boston Scientific Announces Upcoming Investor Conference Schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May. On May 14, 2024, Dan Brennan, executive vice president and chief financial officer, and Ken...

Apr 24, 2024
Boston Scientific Announces Results for First Quarter 2024

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis...

Read more press releases

In the news
Mar 19, 2024
Transforming the future of chronic pain care with Matt McDonald
WIRED Health (sponsored)
A presentation from WIRED Health 2024 discusses how Boston Scientific is advancing technologies to transform chronic pain care today and in the future.
Mar 1, 2024
Boston Scientific claims first US approval for drug-coated coronary balloon
Fierce Biotech

The first coronary drug-coated balloon to be FDA-approved in the U.S., the Boston Scientific AGENTTM Drug-Coated Balloon addresses a clinical unmet need by treating and preventing reoccurrence of in-stent restenosis in patients with coronary artery disease.

Feb 20, 2024
A new tool for treating pulmonary embolism: big data
Fast Company (sponsored)
Boston Scientific shares how real-world data can help optimize physician decision making when treating patients with pulmonary embolism (PE).
Feb 6, 2024
Affordable child care at work a popular perk to get employees back in the office
CBS News
Lisa Considine, vice president of human resources, and Adriana Gonzalez, director of global supply chain, share how Boston Scientific’s on-site day care in Marlborough, MA provides support and flexibility for employees while reinforcing an organizational culture of caring.

Read more news

A game changer for treating atrial fibrillation
2023 Performance Report

When science, humanity and purpose connect, lives can be transformed

View the Report

News alerts

Sign up to receive our press releases via email

Media contacts

Business and enterprise contacts for journalists

Media resources

Imagery and other resources

Top